Screener
Assembly Biosciences ASMB Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Assembly Biosciences’s reported figures.
Based on the most recent quarter.
The source filing: Assembly Biosciences’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211987
FAQ
- What is Assembly Biosciences's debt-to-equity?
- Assembly Biosciences (ASMB) reported debt-to-equity of 0× in Q1 2026.
- How has Assembly Biosciences's debt-to-equity changed year-over-year?
- Assembly Biosciences's debt-to-equity decreased by 88.8% year-over-year, from 0.1× to 0×.
- What is the long-term trend for Assembly Biosciences's debt-to-equity?
- Over 5 years (2020 to 2025), Assembly Biosciences's debt-to-equity has grown at a -21.3% compound annual growth rate (CAGR), from 0× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Assembly Biosciences's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude